Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
In this clinical trial, the investigators want to know if cabazitaxel is more effective than
methotrexate for patients with recurrent or metastatic squamous cell carcinoma of the head
and neck in palliative treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain